Product
ABP 938
2 clinical trials
2 indications
Indication
Chorioretinal Vascular DiseaseIndication
Age-related Macular DegenerationClinical trial
An Open Label, Two-Arm Study in Subjects With Chorioretinal Vascular Disease to Evaluate ABP 938 and Aflibercept (Eylea®) in a Prefilled SyringeStatus: Completed, Estimated PCD: 2023-02-17
Clinical trial
A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular DegenerationStatus: Completed, Estimated PCD: 2022-07-18